IV Iron Replacement for Iron Deficiency in IPAH Patients 2017-03-03T15:38:53+00:00

Clinical Trials

August 15, 2016

IV Iron Replacement for Iron Deficiency in Idiopathic Pulmonary Arterial Hypertension (IPAH) Patients

  • Study Sponsor: Imperial College London
  • Institution: Imperial College London
  • Start Date: April 10, 2011
  • End Date: December 31, 2017
  • Design: Placebo-controlled
  • Age range (years): from 16 to 75
  • Type of PH
    • IPAH
  • Study Duration for individual patient: 24 weeks
  • Contact: Vijay Zala
  • Listing on clinicaltrials.gov